Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,994.00
Bid: 2,004.00
Ask: 2,006.00
Change: 13.00 (0.66%)
Spread: 2.00 (0.10%)
Open: 1,987.00
High: 2,008.00
Low: 1,979.00
Prev. Close: 1,981.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday broker round-up UPDATE

Fri, 18th Jul 2014 07:55

Barclays: Credit Suisse cuts target price from 275p to 235p retaining a neutral rating.Barratt Developments: Liberum Capital reduces target price from 468p to 387p and downgrades to hold.Bellway: Liberum Capital reduces target price from 1900p to 1764p, while leaving its buy recommendation unchanged.Berkeley Group: Liberum Capital cuts target price from 2634p to 2613p retaining a hold recommendation.Bovis Homes Group: Liberum Capital reduces target price from 1034p to 930p and stays with its buy recommendation.Breedon: Jefferies shifts target price from 45p to 47p and reiterates a hold recommendation.British Land: Barclays raises target price from 695p to 936p, while its overweight rating remains unchanged.Burberry Group: Exane upgrades to outperform with a target price of 1700p.bwin.party: Deutsche Bank lowers target price from 110p to 100p and reiterates a hold recommendation.Croda International: Berenberg reduces target price from 2850p to 2700p, while keeping its buy recommendation.Drax Group: UBS moves target price from 790p to 800p and stays with its buy recommendation.GKN: Citi lowers target price from 435p to 410p, while staying with its buy recommendation.Gleeson: Liberum Capital cuts target price from 481p to 466p keeping a buy recommendation.Hays: Credit Suisse lowers target price from 165p to 150p and reiterates an outperform rating.Hikma Pharmaceuticals: Goldman Sachs raises target price from 1800p to 2250p and upgrades to buy.Hochschild Mining: Citi shifts target price from 110p to 116p, but still recommends selling.Howden Joinery: Berenberg initiates with a target price of 390p and a buy recommendation.Lloyds Banking Group: Citi lowers target price from 83p to 80p and retains a neutral rating.ISG: Jefferies shifts target price from 389p to 390p and keeps a buy recommendation.Michael Page: Credit Suisse cuts target price from 530p to 510p and maintains an outperform rating.Persimmon: Liberum Capital reduces target price from 1303p to 1238p and reiterates a hold recommendation.Reckitt Benckiser: Numis initiates with a target price of 5600p and an add rating.Redrow: Liberum Capital cuts target price from 320p to 307p and stays with its buy recommendation.Ricardo: Oriel raises target price to 700p and upgrades from reduce to buy.Robert Walters: Credit Suisse cuts target price from 380p to 360p and stays with its outperform rating.Standard Chartered: Deutsche Bank reduces target price from 1275p to 1160p and maintains a hold recommendation.SThree: Credit Suisse cuts target price from 450p to 420p and downgrades to neutral.Taylor Wimpey: Liberum Capital lowers target price from 132p to 130p maintaining a buy recommendation.Thorntons: Oriel initiates with a target price of 160p and a buy recommendation.William Hill: UBS cuts target price from 420p to 390p and retains a buy recommendation.
More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.